Frontiers in Neurology (May 2020)

The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study)

  • Shinya Tomari,
  • Parker Magin,
  • Daniel Lasserson,
  • Debbie Quain,
  • Jose M. Valderas,
  • Helen M. Dewey,
  • P. Alan Barber,
  • Neil J. Spratt,
  • Neil J. Spratt,
  • Dominique A. Cadilhac,
  • Dominique A. Cadilhac,
  • Valery L. Feigin,
  • Peter M. Rothwell,
  • Hossein Zareie,
  • Carlos Garcia-Esperon,
  • Andrew Davey,
  • Nashwa Najib,
  • Milton Sales,
  • Christopher R. Levi,
  • Christopher R. Levi,
  • Christopher R. Levi

DOI
https://doi.org/10.3389/fneur.2020.00383
Journal volume & issue
Vol. 11

Abstract

Read online

Background: Transient ischemic attack (TIA) and minor stroke (TIAMS) are risk factors for stroke recurrence. Some TIAMS may be preventable by appropriate primary prevention. We aimed to recruit “possible-TIAMS” patients in the INternational comparison of Systems of care and patient outcomes In minor Stroke and TIA (INSIST) study.Methods: A prospective inception cohort study performed across 16 Hunter–Manning region, Australia, general practices in the catchment of one secondary-care acute neurovascular clinic. Possible-TIAMS patients were recruited from August 2012 to August 2016. We describe the baseline demographics, risk factors and pre-event medications of participating patients.Results: There were 613 participants (mean age; 69 ± 12 years, 335 women), and 604 (99%) were Caucasian. Hypertension was the most common risk factor (69%) followed by hyperlipidemia (52%), diabetes mellitus (17%), atrial fibrillation (AF) (17%), prior TIA (13%) or stroke (10%). Eighty-nine (36%) of the 249 participants taking antiplatelet therapy had no known history of cardiovascular morbidity. Of 102 participants with known AF, 91 (89%) had a CHA2DS2-VASc score ≥ 2 but only 47 (46%) were taking anticoagulation therapy. Among 304 participants taking an antiplatelet or anticoagulant agent, 30 (10%) had stopped taking these in the month prior to the index event.Conclusion: This study provides the first contemporary data on TIAMS or TIAMS-mimics in Australia. Community and health provider education is required to address the under-use of anticoagulation therapy in patients with known AF, possibly inappropriate use of antiplatelet therapy and possibly inappropriate discontinuation of antiplatelet or anticoagulation therapy.

Keywords